Gladstone NOW: The Campaign Join Us on the Journey ✕
46 - 60 of 1448 Results Clear All
New study shows red blood cells act as hidden glucose sponges in low-oxygen conditions, explaining why people living at high altitude have lower diabetes rates and pointing toward new treatments.
News Release Research (Publication) Diabetes Jain Lab
Gladstone scientists are developing new AI tools that promise to revolutionize how science is done and lead to new treatments for the most devastating diseases.
AI Srivastava Lab Pollard Lab Engelhardt Lab Theodoris Lab Shipman Lab Ramani Lab Finkbeiner Lab Cardiovascular Disease Neurological Disease
Alisa Dietl brings her international training and clinical perspective to Gladstone, where she works to engineer more effective cancer immunotherapies for solid tumors.
Graduate Students and Postdocs Profile Cancer Pelka Lab
SLAS—Steve Finkbeiner, director of the Center for Systems and Therapeutics, was selected as the recipient of the 2026 Innovation Award by the Society for Laboratory Automation and Screening for his work on AI, robotics, and the thinking microscope.
Gladstone Experts Finkbeiner Lab AI Robotic Microscopy
Three recipients of Gladstone’s Outstanding Mentoring Award share their personal approaches to mentorship and reflect how this passion has shaped their own growth as leaders.
Profile Roan Lab Graduate Students and Postdocs
The New York Times—Katie Pollard, director of the Gladstone Institute of Data Science and Biotechnology, comments on how the 4D Nucleome Project is revealing the way DNA misfolding inside the nucleus can contribute to disease. (Subscription required.)
Gladstone Experts Pollard Lab
The Daily Northwestern—Katie Pollard, director of the Gladstone Institute of Data Science and Biotechnology, explains how the 4D Nucleome Project mapped the genome in 3D to understand how the folding of chromosomes relates to DNA function.
Gladstone Experts Pollard Lab
The Stem Cell Podcast—Gladstone President and Investigator Deepak Srivastava discusses groundbreaking research on heart defects in Down syndrome and ways to encourage the growth of cell and gene therapies.
Gladstone Experts Cardiovascular Disease Srivastava Lab
Development—Gladstone scientists Irfan Kathiriya and Benoit Bruneau comment on their study, which identified the gene TBX5 as a key regulator of the gene regulatory networks governing atrial cell type specification and a potential therapeutic target for genetic atrial diseases.
Gladstone Experts Congenital Heart Disease Cardiovascular Disease Bruneau Lab
Gladstone scientists identified a cellular boundary that guides heart development and revealed how disrupting it can lead to holes in the heart’s wall.
News Release Research (Publication) Congenital Heart Disease Cardiovascular Disease Bruneau Lab
Shyam Jinagal explores how genetics, aging, and regeneration shape the heart—and how those insights could one day restore heart function after injury.
Graduate Students and Postdocs Profile Cardiovascular Disease Srivastava Lab
The Washington Post—As the National Institutes of Health announced it would no longer support research that utilizes fetal tissue, Gladstone Investigator Steve Finkbeiner explains the importance of using this model to better understand Alzheimer’s disease. (Subscription required.)
Gladstone Experts Finkbeiner Lab
Nature—Gladstone Investigator Steve Finkbeiner comments on new restrictions that many scientists believe will slow research on fetal development and stem-cell biology.
Gladstone Experts Finkbeiner Lab
The AI Journal—A collaboration between Topos Bio and the team led by Steve Finkbeiner, director of the Center for Systems and Therapeutics at Gladstone, aims to apply a new approach to neurodegenerative disease.
Gladstone Experts Alzheimer’s Disease Neurological Disease Finkbeiner Lab
A new documentary follows Jim Dunn’s end-of-life decision to donate his tissues to HIV research.
Institutional News HIV/AIDS Infectious Disease Roan Lab
